We observed a strong genome-wide significant signal at 9p24.1 (JAK2) only in post-polycythemia vera MF (Supplemental Table 3 and Supplemental Fig. 3), which is consistent with prior reports of higher JAK2 involvement in patients with polycythemia vera38–40. Here, JAK2 is linked to acquired polycythemia vera.